| Product NDC: | 14537-967 |
| Proprietary Name: | ACD |
| Non Proprietary Name: | Dextrose Monohydrate, Sodium Citrate, and Anhydrous Citric Acid |
| Active Ingredient(s): | .73; 2.45; 2.2 g/100mL; g/100mL; g/100mL & nbsp; Dextrose Monohydrate, Sodium Citrate, and Anhydrous Citric Acid |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 14537-967 |
| Labeler Name: | CaridianBCT, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA010228 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020225 |
| Package NDC: | 14537-967-75 |
| Package Description: | 750 mL in 1 BAG (14537-967-75) |
| NDC Code | 14537-967-75 |
| Proprietary Name | ACD |
| Package Description | 750 mL in 1 BAG (14537-967-75) |
| Product NDC | 14537-967 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dextrose Monohydrate, Sodium Citrate, and Anhydrous Citric Acid |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20020225 |
| Marketing Category Name | ANDA |
| Labeler Name | CaridianBCT, Inc. |
| Substance Name | ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM CITRATE |
| Strength Number | .73; 2.45; 2.2 |
| Strength Unit | g/100mL; g/100mL; g/100mL |
| Pharmaceutical Classes |